4wvp: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structure of an activity-based probe HNE complex== | ==Crystal structure of an activity-based probe HNE complex== | ||
<StructureSection load='4wvp' size='340' side='right' caption='[[4wvp]], [[Resolution|resolution]] 1.63Å' scene=''> | <StructureSection load='4wvp' size='340' side='right'caption='[[4wvp]], [[Resolution|resolution]] 1.63Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4wvp]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4wvp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4WVP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4WVP FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.63Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3V2:[(1R)-1-AMINOPROPYL]PHOSPHONIC+ACID'>3V2</scene>, <scene name='pdbligand=3V3:1-AMINO-3,6,9,12-TETRAOXAPENTADECAN-15-OIC+ACID'>3V3</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=BTN:BIOTIN'>BTN</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=NLB:6-(BENZYLOXY)-L-NORLEUCINE'>NLB</scene>, <scene name='pdbligand=OIC:OCTAHYDROINDOLE-2-CARBOXYLIC+ACID'>OIC</scene>, <scene name='pdbligand=OMT:S-DIOXYMETHIONINE'>OMT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4wvp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wvp OCA], [https://pdbe.org/4wvp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4wvp RCSB], [https://www.ebi.ac.uk/pdbsum/4wvp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4wvp ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Disease == | == Disease == | ||
[ | [https://www.uniprot.org/uniprot/ELNE_HUMAN ELNE_HUMAN] Defects in ELANE are a cause of cyclic haematopoiesis (CH) [MIM:[https://omim.org/entry/162800 162800]; also known as cyclic neutropenia. CH is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity. Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia, affected individuals are at risk for opportunistic infection. Monocytes, platelets, lymphocytes and reticulocytes also cycle with the same frequency.<ref>PMID:14673143</ref> <ref>PMID:10581030</ref> Defects in ELANE are the cause of neutropenia severe congenital autosomal dominant type 1 (SCN1) [MIM:[https://omim.org/entry/202700 202700]. SCN1 is a disorder of hematopoiesis characterized by a maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 10(9)/l and early onset of severe bacterial infections.<ref>PMID:20220065</ref> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/ELNE_HUMAN ELNE_HUMAN] Modifies the functions of natural killer cells, monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis.<ref>PMID:15140022</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 4wvp" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4wvp" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Elastase 3D structures|Elastase 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 27: | Line 29: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Drag | [[Category: Synthetic construct]] | ||
[[Category: Kasperkiewicz | [[Category: Drag M]] | ||
[[Category: Lechtenberg | [[Category: Kasperkiewicz P]] | ||
[[Category: Riedl | [[Category: Lechtenberg BC]] | ||
[[Category: Robinson | [[Category: Riedl SJ]] | ||
[[Category: Robinson HR]] | |||
Latest revision as of 07:37, 27 September 2023
Crystal structure of an activity-based probe HNE complex
| ||||||||||||